Lilly Drug Gains Another FDA Approval
The U.S. Food and Drug Administration has awarded another approval for a drug developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Boehringer Ingelheim in Germany. The company says Jardia... Read More
